For the quarter ending 2026-03-31.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Collaboration revenue | 0 | 1,292 | 1,090 | 1,460 |
| Research and development | 12,951 | 10,985 | 13,820 | 21,031 |
| General and administrative | 7,485 | 6,190 | 6,507 | 7,631 |
| Long-lived asset impairment charge | - | 33,606* | - | - |
| Restructuring charge | - | 907* | - | - |
| Total operating expenses | 20,436 | 51,688 | 20,327 | 28,662 |
| Loss from operations | -20,436 | -50,396 | -19,237 | -27,202 |
| Other income, net | 906 | 990 | 1,176 | 1,433 |
| Total other income, net | 906 | 990 | 1,176 | 1,433 |
| Loss before provision for income taxes | -19,530 | -49,406 | -18,061 | -25,769 |
| Provision for income taxes | 95 | 636 | 0 | 1 |
| Net loss | -19,625 | -50,042 | -18,061 | -25,770 |
| Unrealized gain on available-for-sale marketable securities | -224 | 3 | 48 | -74 |
| Foreign currency translation adjustments, net | -17 | 5 | 11 | 13 |
| Comprehensive loss | -19,832 | -50,044 | -18,024 | -25,857 |
| Basic EPS | -1.69 | -5.315 | -1.92 | -2.74 |
| Diluted EPS | -1.69 | -5.315 | -1.92 | -2.74 |
| Basic Average Shares | 11,598,717 | 9,415,241 | 9,391,559 | 9,390,542 |
| Diluted Average Shares | 11,598,717 | 9,415,241 | 9,391,559 | 9,390,542 |